AbCellera Biologics (ABCL) Times Interest Earned (2020 - 2026)

AbCellera Biologics (ABCL) posted Times Interest Earned of -$15.6 for Q1 2026, down 2970.01% on a QoQ basis from -$0.51 in Q4 2025.

AbCellera Biologics (ABCL) Times Interest Earned (2020 - 2026) Analysis & Trends

AbCellera Biologics' Times Interest Earned history runs 7 years deep, the most recent figure standing at -$15.6 for Q1 2026.

Quarterly Times Interest Earned changed N/A year-over-year to -$15.6 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$57.51 (changed N/A YoY) and the FY2025 annual result came in at -$3.86, up 38.78% from the prior year.
Times Interest Earned was -$15.6 for Q1 2026 at AbCellera Biologics, down from -$0.51 in the prior quarter.
Across five years, Times Interest Earned topped out at $55.67 in Q1 2022 and bottomed at -$17.73 in Q4 2023.
A 5-year average of -$1.42 and a median of -$2.82 in 2022 frame the typical range for Times Interest Earned.
Annual changes were most pronounced in 2022 — Times Interest Earned soared 224.17% — and 2023, when it plunged 529.49%.
AbCellera Biologics' Times Interest Earned stood at -$2.82 in 2022, then plunged by 529.49% to -$17.73 in 2023, then surged by 91.78% to -$1.46 in 2024, then jumped by 65.13% to -$0.51 in 2025, then sank by 2970.01% to -$15.6 in 2026.
Business Quant data shows ABCL's Times Interest Earned at -$15.6 in Q1 2026, -$0.51 in Q4 2025, and -$1.46 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Times Interest Earned (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	658.42
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-157.58
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	7.60
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	2.71
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	22.72
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	-0.38
10	AbCellera Biologics	1.62 Bn	1.62 Bn	-	-15.60

Download Data